ArticleBMC infectious diseases2025
Clinical and CT characteristics of abdominal tuberculous lymphadenopathy: a comparative analysis of hematogenous and non-hematogenous dissemination.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The portacaval space: imaging essentials.Abdominal radiology (New York) · 2026Review
- Diagnostic Imaging of Extrapulmonary Tuberculosis Across Organ Systems.Diagnostics (Basel, Switzerland) · 2026Review
- Article
- Clinical and CT Features of HIV-Negative and HIV-Positive Patients with Abdominal Tuberculous Lymphadenopathy.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesTo elucidate the differences in clinical and CT manifestations between abdominal tuberculous lymphadenopathy (ATBL) resulting from hematogenous and non-hematogenous dissemination.
methodsA retrospective analysis was conducted on the clinical records and CT data of 178 untreated ATBL patients from January 2012 to March 2023. Patients were categorized into two groups: hematogenous dissemination (75 cases) and non-hematogenous dissemination (103 cases). The clinical characteristics of the two groups of patients were compared, and the CT imaging features of ATBL (such as location, size, and enhancement degree) were evaluated. Statistical analyses were performed using Student's t-test or Mann-Whitney U test and Chi-squared test to identify significant differences between the groups.
resultsThe study found that the non-hematogenous dissemination group had a higher prevalence of males, younger patients, abdominal distension, and positive tuberculin skin test (TST) results, along with higher CD4
conclusionThere are differences in the clinical and CT manifestations of ATBL caused by hematogenous versus non-hematogenous dissemination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.